Replies to post #161027 on OWC Pharmaceutical Research Corp (OWCP)

[CashMoney75]

Man that sucks. Sorry.

[KrakenTaken]

could be worse you could be me who fell for their pipe dream scam sales man Jeff Smucklick and sold your free trading shares you bought for .0312 at .65 to buy restricted shares at .50 with warrants at 1.00 under the impression they actually had a trial and product coming soon only to do that and then watch the stock run to $3 not be able to sell your shares then find out how hard it is to find a broker to deposit those shares watch your position fall from a potential million dollar position to under 100k and being on the hook with the IRS for over $30k due to you selling the stock at .65 to buy the restricted shares and then not even having the money left once you sold your shares to pay your taxes... yeah thats me so dont feel so bad cherry i know you are retired and this was part of your nest egg i am sorry me i am 32 i will bounce back but i have to live with myself for the rest of my life knowing that i fell for a scam and had the potential for life changing money for my family my 3 kids , i was raised by a single mom we had nothing growing up i watched her work 3 jobs just to make ends meat.. i thought this was my ticket and it was but i fell for the scam i fell for what i thought was a real company, people who i trusted people i thought were a friend.. keep your head up, wish you all the best, God Bless

[skitahoe]

Cherry, while I haven't lost that much, it still hurts, and I don't believe the company can justify the sort of reverse split mentioned in their draft. There are currently under 160 million shares outstanding, this figure isn't unreasonable, but a move to reduce the shares to under 100 million might be something that could be justified, I.E. a 1 for 2. Clearly taking the shares outstanding to one hundredth or less of the current O/S is purely a move to effectively eliminate current shareholders to a position of owning about 1% of the company after they once again dilute to over 100 million shares, which such a company should justify.

I fully support the goal of achieving a Nasdaq listing, but not through an extreme reverse split. I believe it should be done by raising the value of the share price through their actions. The company needs to be open with things like planned clinical trials by putting them into the clinical trials database, they need to discuss the status of their patents, in short they need to discuss the business plan. I believe that if they were open about what the company represents our share price would be far closer, if not over $1, if it were at that sort of price, I believe that bringing just one product to market could bring the share price to above the $4 required for a Nasdaq listing with no R/S, but if they wished to make it sooner, a 1 for 2 would seem reasonable. What they are proposing isn't reasonable, it's purely a vehicle to permit massive dilution after the reverse split. I believe that investors should attempt to defeat such actions by the company and push for disclosure of all the work the company is doing to properly value the stock.

Gary